ROCHE REDUCTIONS: The Swiss drugmaker will close its Nutley, N.J., site, the former U.S. headquarters, by end of 2013 in a money-saving consolidation of research and development programs.
JOB CUTS: Roche will eliminate the remaining 1,000 jobs at Nutley, mostly researchers working on drugs for cancer, arthritis and hepatitis. Those projects will be shifted to other Roche sites or, for less-promising ones, eliminated.
In-depth coverageas the midterms
take shape.
Follow the latest midterm news, analysis, and expert perspectives with unlimited access.
See Subscription Options
Already a member? Log in
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.